company background image
PBH logo

Prestige Consumer Healthcare Informe acción NYSE:PBH

Último precio

US$82.67

Capitalización de mercado

US$4.1b

7D

0.4%

1Y

41.8%

Actualizada

20 Nov, 2024

Datos

Finanzas de la empresa +

Prestige Consumer Healthcare Inc.

Informe acción NYSE:PBH

Capitalización de mercado: US$4.1b

Resumen de acción PBH

Prestige Consumer Healthcare Inc., junto con sus filiales, desarrolla, fabrica, comercializa, distribuye y vende productos de venta libre para la salud y el cuidado personal en Norteamérica, Australia e internacionalmente. Saber más

Análisis fundamental de PBH
Puntuación del snowflake
Valoración5/6
Crecimiento futuro1/6
Rendimiento pasado3/6
Salud financiera4/6
Dividendos0/6

Recompensas

Cotiza un 46.4% por debajo de nuestra estimación de su valor justo

Se prevé un crecimiento anual de los beneficios de 5.26%

Ha pasado a ser rentable este año

Cotiza a buen valor en comparación con empresas similares e industria

Análisis de riesgos

Tiene un alto nivel de endeudamiento

Venta significativa por parte de personas con información privilegiada en los últimos 3 meses


Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WA
WarrenAI
Based on Analyst Price Targets

International Expansion And Decisive Investments Brighten Earnings Prospects

Key Takeaways Supply chain improvements for Clear Eyes and international expansion of Hydralyte promise revenue growth and market stabilization. Focus on debt reduction and share repurchases suggests improved EPS through lower leverage and strategic capital allocation.
View narrative
US$85.29
FV
3.1% undervalued intrinsic discount
2.59%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
1 day ago author updated this narrative

Competidores de Prestige Consumer Healthcare Inc.

Organon

NYSE:OGN

US$3.8b

Elanco Animal Health

NYSE:ELAN

US$6.6b

Corcept Therapeutics

NasdaqCM:CORT

US$5.7b

Supernus Pharmaceuticals

NasdaqGM:SUPN

US$2.0b

Historial de precios y rendimiento

Resumen de todos los máximos históricos, cambios y caídas de precios de Prestige Consumer Healthcare
Precios históricos de las acciones
Precio actual de la acciónUS$82.67
Máximo en las últimas 52 semanasUS$83.83
Mínimo de 52 semanasUS$56.61
Beta0.47
1Cambio en 1 mes15.95%
Variación en 3 meses16.60%
Cambio de 1 año41.83%
3Variación en 3 años39.15%
Variación en 5 años117.04%
Variación desde la OPV365.75%

Noticias y actualizaciones recientes

We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Nov 03
We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Recent updates

We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Nov 03
We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Popularity With Investors Is Under Threat From Overpricing

Sep 10
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Popularity With Investors Is Under Threat From Overpricing

Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Jul 16
Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Revenues Not Telling The Story For Prestige Consumer Healthcare Inc. (NYSE:PBH)

May 22
Revenues Not Telling The Story For Prestige Consumer Healthcare Inc. (NYSE:PBH)

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Mar 26
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 50% Undervalued

Mar 05
An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 50% Undervalued

Prestige Consumer Healthcare Inc. (NYSE:PBH) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Feb 11
Prestige Consumer Healthcare Inc. (NYSE:PBH) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Shares May Have Run Too Fast Too Soon

Feb 05
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Shares May Have Run Too Fast Too Soon

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Dec 14
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Sep 10
Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Prestige Consumer Healthcare: Unproductive Buyback And Excessive Valuation

Aug 15

Is Prestige Consumer Healthcare (NYSE:PBH) Using Too Much Debt?

Jun 12
Is Prestige Consumer Healthcare (NYSE:PBH) Using Too Much Debt?

An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 43% Undervalued

May 20
An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 43% Undervalued

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has Caught The Eye Of Investors

Mar 17
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has Caught The Eye Of Investors

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Mar 02
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 75% Above Its Share Price

Feb 08
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 75% Above Its Share Price

Prestige Consumer Healthcare reports Q3 earnings beat; updates FY23 guidance

Feb 02

Prestige Consumer Healthcare: Taking My Winnings Off The Table

Jan 19

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Nov 23
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare GAAP EPS of $1.02 beats by $0.02, revenue of $289.3M beats by $6.07M

Nov 03

Holding Prestige Consumer Healthcare

Aug 31

If EPS Growth Is Important To You, Prestige Consumer Healthcare (NYSE:PBH) Presents An Opportunity

Aug 26
If EPS Growth Is Important To You, Prestige Consumer Healthcare (NYSE:PBH) Presents An Opportunity

We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Aug 05
We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Prestige Consumer Healthcare GAAP EPS of $1.09 beats by $0.05, revenue of $277.1M beats by $8.18M

Aug 04

Should You Be Adding Prestige Consumer Healthcare (NYSE:PBH) To Your Watchlist Today?

May 27
Should You Be Adding Prestige Consumer Healthcare (NYSE:PBH) To Your Watchlist Today?

Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

May 05
Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

Does Prestige Consumer Healthcare (NYSE:PBH) Deserve A Spot On Your Watchlist?

Feb 22
Does Prestige Consumer Healthcare (NYSE:PBH) Deserve A Spot On Your Watchlist?

Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

Feb 03
Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Extensively

Nov 04
These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Extensively

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has A Meaningful Debt Burden

Aug 06
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has A Meaningful Debt Burden

Rentabilidad de los accionistas

PBHUS PharmaceuticalsMercado US
7D0.4%-3.8%-1.0%
1Y41.8%9.8%30.3%

Rentabilidad vs. Industria: PBH superó a la industria US Pharmaceuticals, que obtuvo un rendimiento del 9.8% el año pasado.

Rentabilidad vs. Mercado: PBH superó al mercado US, que obtuvo un rendimiento del 30.3% el año pasado.

Volatilidad de los precios

Is PBH's price volatile compared to industry and market?
PBH volatility
PBH Average Weekly Movement2.7%
Pharmaceuticals Industry Average Movement9.6%
Market Average Movement6.2%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market3.1%

Precio estable de las acciones: PBH no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de PBH (3%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
1996570Ron Lombardiwww.prestigebrands.com

Prestige Consumer Healthcare Inc., junto con sus filiales, desarrolla, fabrica, comercializa, distribuye y vende productos de venta libre para la salud y el cuidado personal en Norteamérica, Australia e internacionalmente. La empresa opera en dos segmentos, OTC Healthcare norteamericano y OTC Healthcare internacional. Ofrece polvos analgésicos bajo las marcas BC y Goody's; tratamientos para la dermatitis del pañal y protectores de la piel para bebés bajo la marca Boudreaux's Butt Paste; sprays y pastillas para aliviar el dolor de garganta y de boca bajo la marca Chloraseptic; productos para el cuidado de los ojos que alivian el enrojecimiento y el picor bajo la marca Clear Eyes; eliminación casera de verrugas comunes y plantares bajo la marca Compound W; y Debrox para eliminar la cera de los oídos.

Resumen de fundamentos de Prestige Consumer Healthcare Inc.

¿Cómo se comparan los beneficios e ingresos de Prestige Consumer Healthcare con su capitalización de mercado?
Estadísticas fundamentales de PBH
Capitalización bursátilUS$4.07b
Beneficios(TTM)US$205.95m
Ingresos (TTM)US$1.11b

19.8x

Ratio precio-beneficio (PE)

3.7x

Ratio precio-ventas (PS)

¿Está PBH sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de PBH
IngresosUS$1.11b
Coste de los ingresosUS$488.55m
Beneficio brutoUS$622.11m
Otros gastosUS$416.16m
BeneficiosUS$205.95m

Últimos beneficios comunicados

Sep 30, 2024

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)4.17
Margen bruto56.01%
Margen de beneficio neto18.54%
Ratio deuda/patrimonio60.7%

¿Cómo se ha desempeñado PBH a largo plazo?

Ver rendimiento histórico y comparativa